Form4insider filings, from the source

Insider holders · CIK 0000887247

Adamis Pharmaceuticals Corp · ADMP

Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity

InsiderDirect sharesIndirect sharesTotal reportedLast report (ET)From
Eses Holdings (FZE)10% Owner—1,635,3121,635,312Feb 13, 2015 · 5:24 pm ESTForm 4
Ahmed Shayan Fazlur Rahman10% Owner—1,635,3121,635,312Feb 13, 2015 · 5:24 pm ESTForm 4
Eddie Wabern GloverCEO of US Compounding, Inc.741,668—741,668Feb 12, 2019 · 6:44 pm ESTForm 5
David J. MarguglioSVP and Chief Business Officer401,0135,884406,897Feb 25, 2019 · 7:17 pm ESTForm 4
Robert O HopkinsChief Financial Officer356,807—356,807Feb 25, 2019 · 7:13 pm ESTForm 4
Ronald B. MossChief Medical Officer291,643—291,643Feb 25, 2019 · 7:16 pm ESTForm 4
Karen K. DanielsVP of Operations193,855—193,855Feb 25, 2019 · 7:14 pm ESTForm 4
Richard C WilliamsDirector189,918—189,918May 27, 2016 · 5:18 pm EDTForm 4
Robert B RothermelDirector127,000—127,000May 27, 2016 · 4:50 pm EDTForm 4
William C DenbyDirector102,500—102,500May 27, 2016 · 4:44 pm EDTForm 4
Dennis J Carlo Ph.D.President & CEO13,8965,88319,779Feb 12, 2019 · 6:45 pm ESTForm 5

Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.